Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.

Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.

Item
http://www.wikidata.org/entity/Q33525354
Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Drug delivery strategies for Alzheimer's disease treatment.Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type.Drug treatments for the neuropsychiatric complications of Parkinson's disease.Risk of pneumonia in new users of cholinesterase inhibitors for dementiaEfficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents
P2860

Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.

Item
http://www.wikidata.org/entity/Q33525354
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety and tolerability of riv ...... ta from three clinical trials.
@ast
Safety and tolerability of riv ...... ta from three clinical trials.
@en
Safety and tolerability of riv ...... ta from three clinical trials.
@nl
type
label
Safety and tolerability of riv ...... ta from three clinical trials.
@ast
Safety and tolerability of riv ...... ta from three clinical trials.
@en
Safety and tolerability of riv ...... ta from three clinical trials.
@nl
prefLabel
Safety and tolerability of riv ...... ta from three clinical trials.
@ast
Safety and tolerability of riv ...... ta from three clinical trials.
@en
Safety and tolerability of riv ...... ta from three clinical trials.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Safety and tolerability of riv ...... ta from three clinical trials.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1742-1241.2009.02253.X
P433
P478
P577
P698